Canadian Society of Clinical Chemists (CSCC) consensus guidance for testing, selection and quality management of SARS-CoV-2 point-of-care tests.
Clin Biochem
; 95: 1-12, 2021 Sep.
Article
in English
| MEDLINE | ID: covidwho-1242901
ABSTRACT
OBJECTIVES:
A consensus guidance is provided for testing, utility and verification of SARS-CoV-2 point-of-care test (POCT) performance and implementation of a quality management program, focusing on nucleic acid and antigen targeted technologies. DESIGN ANDMETHODS:
The recommendations are based on current literature and expert opinion from the members of Canadian Society of Clinical Chemists (CSCC), and are intended for use inside or outside of healthcare settings that have varied levels of expertise and experience with POCT. RESULTS ANDCONCLUSIONS:
Here we discuss sampling requirements, biosafety, SARS-CoV-2 point-of-care testing methodologies (with focus on Health Canada approved tests), test performance and limitations, test selection, testing utility, development and implementation of quality management systems, quality improvement, and medical and scientific oversight.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Societies, Scientific
/
Practice Guidelines as Topic
/
Consensus
/
Point-of-Care Testing
/
SARS-CoV-2
/
COVID-19
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
/
Qualitative research
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Clin Biochem
Year:
2021
Document Type:
Article
Affiliation country:
J.clinbiochem.2021.05.010
Similar
MEDLINE
...
LILACS
LIS